Orphazyme Feed

Land	Danmark
Lista	Small Cap Copenhagen
Sektor	Hälsovård
Industri	Bioteknik

2023-11-30 11:05:11 Finanskalender 2024 -4,49%

2023-11-30 11:01:56 Minutes of the Extraordinary General Meeting of Orphazyme A/S -4,49%

2023-11-08 18:28:20 Notice of Extraordinary General Meeting in Orphazyme A/S +3,53%

2023-11-08 18:23:50 Business update October 2023 +3,53%

2023-11-02 10:42:13 Process for reverse share split at a consolidation ratio of 1.000:1 -8,07%

2023-11-02 10:35:37 Decisions of extraordinary general assembly -8,07%

2023-10-11 10:58:26 Notice convening the Extraordinary General Meeting of Orphazyme A/S +14,38% | 0,01 MDKK

2023-10-11 10:53:38 Notice of proposal to Consolidate Shares in Orphazyme A/S +14,38% | 0,01 MDKK

2023-10-06 08:37:25 Share-based incentive program +4,15% | 0,04 MDKK

2023-10-06 07:55:35 Preliminary court approval on US Security class action case +4,15% | 0,04 MDKK

2023-09-20 20:52:20 New CEO appointed -5,78% | 0,02 MDKK

2023-09-12 08:30:00 Interim Report First Half 2023 -5,10% | 0,11 MDKK

2023-05-30 19:41:56 Change in management +15,56% | 13,5 MDKK

2023-05-19 09:21:45 Major shareholder announcement +37,00% | 1,33 MDKK

2023-05-17 18:51:34 Major shareholder announcement +37,00% | 1,33 MDKK

2023-05-17 15:29:42 Resolutions passed at the Annual General Meeting +6,95% | 0,09 MDKK

2023-05-17 12:44:58 Changes to the Board of Directors +6,95% | 0,09 MDKK

2023-05-12 18:02:12 Major shareholder announcement -1,03% | 0,12 MDKK

2023-05-09 10:45:00 Major shareholder announcement -0,84% | 0,09 MDKK

2023-05-09 10:35:00 Major shareholder announcement -0,84% | 0,09 MDKK

2023-04-25 22:27:00 Notice to convene Annual General Meeting +6,67% | 2,74 MDKK

2023-04-25 22:20:00 Orphazyme Announces Publication of 2022 Financial Results and Annual Report +6,67% | 2,74 MDKK

2023-04-17 08:52:24 Change to Financial Calendar for 2023 and update regarding class action lawsuit in United States -1,15% | 0,27 MDKK

2022-09-26 17:25:29 Orphazyme reports financial results in Interim Report First Half 2022 +6,15% | 0,07 MDKK

2022-09-25 22:09:16 Adjusted financial outlook for 2022 -4,76% | 0,10 MDKK

2022-09-19 19:41:51 Updated financial calendar for 2022 +2,08% | 0,17 MDKK

2022-06-29 16:27:05 Resolutions passed at the Annual General Meeting -4,75% | 0,21 MDKK

2022-06-20 19:50:13 Updated notice to holders of ADSs regarding termination of Deposit Agreement +4,10% | 0,29 MDKK

2022-06-08 23:07:32 Correction: Orphazyme Announces Publication of 2021 Financial Results and Annual Report -2,17% | 0,31 MDKK

2022-06-07 23:47:03 Notice to convene Annual General Meeting -7,63% | 0,41 MDKK

2022-06-07 23:34:17 Orphazyme Announces Publication of 2021 Financial Results and Annual Report -7,63% | 0,41 MDKK

2022-05-31 18:57:57 Orphazyme completes sale of substantially all of its assets and business activities to KemPharm +22,74% | 1,30 MDKK

2022-05-30 14:55:12 Restructuring proposal adopted by creditors +31,01% | 0,54 MDKK

2022-05-23 08:52:08 Changes to the Board of Directors -5,92% | 0,23 MDKK

2022-05-18 16:35:30 Restructuring Proposal -3,74% | 0,29 MDKK

2022-05-16 14:50:25 Updated Financial Calendar for 2022 -5,30% | 1,25 MDKK

2022-05-15 23:00:00 Orphazyme A/S under In-Court-Restructuring to sell substantially all of its assets and business activities to KemPharm, Inc. -5,30% | 1,25 MDKK

2022-04-29 08:46:58 Orphazyme announces update on in-court restructuring proceedings -0,51% | 1,67 MDKK

2022-04-28 16:13:58 Updated Financial Calendar for 2022 -1,21% | 0,40 MDKK

2022-04-07 12:08:00 Statutory restructuring plan adopted by creditors -43,34% | 3,06 MDKK

2022-04-06 14:48:42 Updated Financial Calendar for 2022 -2,52% | 1,36 MDKK

2022-04-06 10:00:00 Notice received from the Depositary to holders of ADSs regarding termination of Deposit Agreement -2,52% | 1,36 MDKK

2022-04-04 19:44:00 Correction: Proposal for a statutory restructuring plan -0,10% | 1,18 MDKK

2022-03-31 23:37:01 Voluntary delisting of ADSs has become effective -7,78% | 3,20 MDKK

2022-03-31 18:00:00 Proposal for a statutory restructuring plan -7,78% | 3,20 MDKK

2022-03-29 13:15:00 Updated Financial Calendar for 2022 +3,45% | 0,47 MDKK

2022-03-22 11:54:06 Orphazyme announces withdrawal of European Marketing Authorisation Application for arimoclomol for the treatment of Niemann-Pick disease type C +5,90% | 4,21 MDKK

2022-03-21 22:44:00 Orphazyme A/S has filed for voluntary delisting of ADSs +5,90% | 4,21 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2024-08-20	Kvartalsrapport 2024-Q2
2024-04-11	Årsstämma 2024
2024-04-04	Bokslutskommuniké 2023
2023-12-06	Split ORPHA 1000:1
2023-11-02	Extra Bolagsstämma 2023
2023-09-12	Kvartalsrapport 2023-Q2
2023-05-22	Ordinarie utdelning ORPHA 0.00 DKK
2023-05-17	Årsstämma 2023
2023-04-25	Bokslutskommuniké 2022
2022-09-26	Kvartalsrapport 2022-Q2
2022-06-29	Årsstämma 2022
2022-06-28	Ordinarie utdelning ORPHA 0.00 DKK
2022-06-07	Bokslutskommuniké 2021
2022-02-15	Extra Bolagsstämma 2022
2021-08-31	Kvartalsrapport 2021-Q2
2021-03-26	Ordinarie utdelning ORPHA 0.00 DKK
2021-03-25	Årsstämma 2021
2021-03-02	Bokslutskommuniké 2020
2020-09-21	Extra Bolagsstämma 2020
2020-08-28	Kvartalsrapport 2020-Q2
2020-03-27	Ordinarie utdelning ORPHA 0.00 DKK
2020-03-26	Årsstämma 2020
2020-02-28	Bokslutskommuniké 2019
2020-01-25	Extra Bolagsstämma 2019
2019-08-28	Kvartalsrapport 2019-Q2
2019-03-28	Ordinarie utdelning ORPHA 0.00 DKK
2019-03-27	Årsstämma 2019
2019-03-01	Bokslutskommuniké 2018
2018-08-28	Kvartalsrapport 2018-Q2
2018-04-13	Ordinarie utdelning ORPHA 0.00 DKK
2018-04-12	Årsstämma 2018
2018-03-15	Bokslutskommuniké 2017

Orphazyme

Kalender

Beskrivning

Orphazyme

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden